Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TYMP | P19971 | 6/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | TK1 | P04183 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | TK2 | O00142 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12111912 | 0.85 | CYP3A4 (0.37) | CYP3A4MAPK1ALDH1A1MEN1KMT2A | |
| SCHEMBL29557740 | 0.79 | ALDH1A1 (0.35) | CYP3A4MAPK1ALDH1A1TYMPMEN1 | |
| SCHEMBL9374505 | 0.78 | OPRM1 (0.40) | ALDH1A1POLB | |
| SCHEMBL14414820 | 0.78 | OPRM1 (0.40) | ALDH1A1POLB | |
| SCHEMBL20285415 | 0.78 | OPRM1 (0.40) | ALDH1A1POLB | |
| SCHEMBL21682012 | 0.77 | SMYD2 (0.39) | CYP3A4ALDH1A1 | |
| SCHEMBL17198303 | 0.77 | SMYD2 (0.39) | CYP3A4ALDH1A1 | |
| SCHEMBL7850077 | 0.76 | ALDH1A1 (0.60) | MAPK1ALDH1A1KMT2APOLBHPGD | |
| SCHEMBL12556315 | 0.76 | ALDH1A1 (0.60) | MAPK1ALDH1A1KMT2APOLBHPGD | |
| SCHEMBL13672341 | 0.76 | ALDH1A1 (0.60) | MAPK1ALDH1A1KMT2APOLBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3999118-A1 | ANTIBODY-STING AGONIST CONJUGATES AND THEIR USE IN IMMUNOTHERAPY | Immunesensor Therapeutics, Inc. (US) | 2022-05-25 | — | — | EP | disclosed |
| US-6562514-B1 | Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries | PINNACLE VRB LIMITED (AU) | 2003-05-13 | — | — | US | disclosed |
| US-6468688-B2 | CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE | PINNACLE VRB LIMITED (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| US-4133817-A | 11-Oxa-prostaglandin analogs | CHEMBRO HOLDINGS (PROPRIETARY) LIMITED (ZA) | 1979-01-09 | — | — | US | disclosed |